Pharmacology of Aprotinin and Efficacy During Cardiopulmonary Bypass
- 1 June 1989
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 7 (2) , 127-140
- https://doi.org/10.1111/j.1527-3466.1989.tb00521.x
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- EFFECT OF APROTININ ON BLOOD LOSS IN REPEAT OPEN-HEART SURGERYThe Lancet, 1988
- Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac SurgeryNew England Journal of Medicine, 1986
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Effect of the protease inhibitor aprotinin on renal hemodynamics in the pig.Hypertension, 1985
- Hochdosierte Aprotinin (Trasylol)-Therapie —unschädlich für die Niere?Langenbecks Archives Of Surgery, 1983
- Participation of kinins or prostaglandins in SQ 14,551-induced immediate decrease of blood pressure in anesthetized dogs.The Japanese Journal of Pharmacology, 1983
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- Complement and Leukocyte-Mediated Pulmonary Dysfunction in HemodialysisNew England Journal of Medicine, 1977